ObsEva SA, en liquidation is a Switzerland-based company which provides services in the fields of research, development, manufacture, registration, promotion and marketing of biotechnical and pharmaceutical products.

Employees

Sector

Biotechnology & Medical Research

More about the company

Market Cap	4.1M 3.56M 3.32M 3.05M 5.77M 390M 5.83M 39.14M 15.3M 195M 15.4M 15.06M 646M	P/E 2021	-2.57x	P/E 2022	-0.45x
Enterprise Value	-1.3M -1.13M -1.05M -964K -1.82M -123M -1.84M -12.37M -4.83M -61.62M -4.87M -4.76M -204M	EV / Sales 2021	-	EV / Sales 2022	0.65x
Free-Float	70.16%	Yield 2021 *	-	Yield 2022	-

23-04-20	ObsEva to Suspend Reporting With SEC Following Delisting From Nasdaq	MT
23-04-20	ObsEva to Change Central Securities Depositary to SIX SIS; Shares Up 9%	MT
23-04-11	Insider Buy: Obseva	MT
23-04-05	ObsEva SA announced that it has received CHF 0.344 million in funding	CI
23-03-31	ObsEva SA Reports Earnings Results for the Full Year Ended December 31, 2022	CI
23-03-30	ObsEva SA Auditor Raises 'Going Concern' Doubt	CI
23-03-22	ObsEva SA(OTCPK:OBSV.F) dropped from NASDAQ Composite Index	CI
23-03-15	ObsEva to Delist from Nasdaq, Deregister from US SEC	MT
23-03-13	ObsEva Names New CEO From May, Appoints Interim Chairman	MT
23-03-13	ObsEva Names New Interim Chairman, CEO as Reorganization Continues	MT
23-03-13	ObsEva SA Announces CEO Changes, Effective on or About May 1, 2023	CI
23-03-13	ObsEva SA Announces Executive Changes	CI
23-03-03	Top Premarket Gainers	MT

22-08-30	HC Wainwright Downgrades ObsEva to Neutral from Buy	MT
22-08-01	Canaccord Genuity Downgrades ObsEva to Hold From Buy, Adjusts Price Target to $1 From $12	MT
22-07-29	Cantor Fitzgerald Cuts ObsEva to Neutral From Overweight, Price Target to $1 From $6	MT
22-06-03	Cantor Fitzgerald Starts ObsEva at Overweight With $6 Price Target	MT
22-04-26	Canaccord Genuity Starts ObsEva at Buy With $12 Price Target	MT

23-04-20	ObsEva Announces Change of Central Securities Depositary	GL
23-04-20	ObsEva Announces Change of Central Securities Depositary	GL
23-03-31	ObsEva Files Year End 2022 Financial Statements	GL
23-03-22	OBSEVA SA : Other Events (form 8-K)	AQ
23-03-15	ObsEva : Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange - Form 8-K	PU

23-04-20	Obseva-Aktien erhalten im Zuge von Nasdaq-Dekotierung neue ISIN-Nummer
23-04-06	Bourse Zurich: le SMI maintient ses gains à l'approche de la mi-journée
23-04-06	Bourse Zurich: ouverture en hausse avant le long week-end pascal
23-03-31	Obseva bleibt 2022 tief in den roten Zahlen
23-03-31	Obseva reste profondément en rouge en 2022, doutes sur la suite

ObsEva SA Stock Swiss Exchange

Stocks

OBSN

CH1260041939

Biotechnology & Medical Research

Valuation: ObsEva SA

Latest news : ObsEva SA

Analysts' recommendations: ObsEva SA

Press Releases: ObsEva SA

News in other languages: ObsEva SA

Quotes and Performance

Bio Therapeutic Drugs

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
OBSEVA SA	-76.92%	-86.36%	-	-	117
WUXI APPTEC CO., LTD.	+10.00%	+14.90%	+53.89%	+87.07%	62.53B
ARGENX SE	+3.10%	-3.20%	+25.34%	+69.83%	52.43B
BIONTECH SE	-0.98%	-1.19%	-16.98%	-14.21%	23.1B
INSMED INCORPORATED	+0.30%	-5.17%	-11.23%	+349.07%	21.4B
GENMAB A/S	+0.84%	+1.37%	+32.25%	-25.52%	17.76B
PHARMAESSENTIA CORPORATION	+4.29%	+8.97%	+200.03%	+341.85%	15.47B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+2.08%	-1.17%	+13.58%	+612.75%	14.68B
EXELIXIS, INC.	+1.71%	-0.90%	+52.13%	+176.27%	14.08B
ARROWHEAD PHARMACEUTICALS, INC.	+4.16%	+4.44%	+444.12%	+183.06%	12.62B
Average	-5.03%	+0.99%	+88.13%	+197.80%	26.01B
Weighted average by Cap.	+4.21%	+1.83%	+60.96%	+148.97%

	2021	2022
Net sales	-	19.64M 17.05M 15.9M 14.6M 27.62M 1.87B 27.92M 187M 73.27M 934M 73.74M 72.13M 3.09B
Net income	-58.38M -50.69M -47.26M -43.42M -82.11M -5.55B -83.01M -557M -218M -2.78B -219M -214M -9.2B	-29.88M -25.94M -24.19M -22.22M -42.03M -2.84B -42.49M -285M -111M -1.42B -112M -110M -4.71B
Net Debt	-28.08M -24.38M -22.73M -20.88M -39.49M -2.67B -39.92M -268M -105M -1.33B -105M -103M -4.42B	-5.4M -4.69M -4.37M -4.01M -7.59M -513M -7.67M -51.51M -20.14M -257M -20.27M -19.82M -850M